RxDoctor Payments Data

Laura Buccheri-Zappi, MD

Procedural Dermatology · New York, NYNPI 1275689333

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 40.3% of the total. Reporting peaked in 2019 at $193 and has fallen 88.8% since, to $22 in 2025. That places this record below the midpoint for procedural dermatology clinicians in NY, where the typical reported total is $3,601.

$381in general payments, 2019–2025

Across 23 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$153
  • EPI Health, LLC$49
  • Galderma Laboratories, L.p.$44
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$34
  • Novartis$25
  • Mayne Pharma Commercial LLC$22
  • plus $54 from 4 others

What the payments were for

  • Food & beverage$381100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$381 in reported general payments places this provider in the 25th percentile of 69 procedural dermatology providers in New York.

See all procedural dermatology providers in New York

Medicare billing

Part B allowed, 2024
$283,134
Medicare patients
605
Services billed
3,632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate42$1,782
Ketoconazole113$1,613
Betamethasone Dipropionate26$1,218
Fluocinonide18$1,034
Ciclopirox33$1,003
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc14$963
Triamcinolone Acetonide117$954
Desonide20$925
Metronidazole16$623
Minoxidil48$504
Mometasone Furoate23$491
ValacyclovirValacyclovir Hcl24$378
Mupirocin34$306
Econazole Nitrate12$255
Cefdinir11$198

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →